These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30092149)

  • 1. Combination therapies for hypertension - why we need to look beyond RAS blockers.
    Gorostidi M; de la Sierra A
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):841-853. PubMed ID: 30092149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hypertension with fixed-dose triple-combination treatments.
    Epstein BJ; Shah NK; Borja-Hart NL
    Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
    Thomopoulos C; Katsimagklis G; Archontakis S; Skalis G; Makris T
    Curr Vasc Pharmacol; 2017; 16(1):61-65. PubMed ID: 28413969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Office and ambulatory blood pressure control in hypertensive patients treated with different two-drug and three-drug combinations.
    de la Sierra A; Banegas JR; Vinyoles E; Gorostidi M; Segura J; de la Cruz JJ; Ruilope LM
    Clin Exp Hypertens; 2016; 38(4):409-14. PubMed ID: 27159660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy as first-line treatment for hypertension.
    Crawford MH
    Am J Cardiovasc Drugs; 2009; 9(1):1-6. PubMed ID: 19178127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with Renin-Angiotensin-aldosterone receptor blockers for hypertension: how far have we come?
    Weir MR; Bakris GL
    J Clin Hypertens (Greenwich); 2008 Feb; 10(2):146-52. PubMed ID: 18256579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence?
    Taddei S
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):185-94. PubMed ID: 25850749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
    Lazich I; Bakris GL
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
    Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
    Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-pill combination for treatment of hypertension: Just a matter of practicality or is there a real clinical benefit?
    Coca A; Whelton SP; Camafort M; López-López JP; Yang E
    Eur J Intern Med; 2024 Aug; 126():16-25. PubMed ID: 38653633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.
    Volpe M; Santolamazza C; Mastromarino V; Coluccia R; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):255-263. PubMed ID: 28608025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.
    Volpe M; Tocci G; de la Sierra A; Kreutz R; Laurent S; Manolis AJ; Tsioufis K
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):463-472. PubMed ID: 29086364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension management: rationale for triple therapy based on mechanisms of action.
    Neutel JM; Smith DH
    Cardiovasc Ther; 2013 Oct; 31(5):251-8. PubMed ID: 23121769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
    Schmieder RE
    Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial Hypertension - when are which combination therapies useful?].
    Brenner R; Rimoldi SF; Rexhaj E; Allemann Y
    Ther Umsch; 2012 May; 69(5):305-13. PubMed ID: 22547363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.